SEC
SlamSEC
SearchBrowseEarnings

BridgeBio Pharma, Inc.

Nasdaq:BBIO
Pharmaceutical Preparations·PALO ALTO, CA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Credit & Agreementsmaterial agreements · debt obligations

Credit & Agreements (8-K)

19 shown
FiledDescription
1/21/26
1.012.03
Material Agreement · New Debt Obligation
→
7/2/25
1.012.03
Material Agreement · New Debt Obligation
→
2/28/25
1.011.022.03
Material Agreement · Agreement Terminated · New Debt Obligation
→
8/21/24
1.01
Material Agreement
→
3/6/24
1.01
Material Agreement
→
3/4/24
1.01
Material Agreement
→
↓ 13 more
CEO
Kumar Neil
CFO
Trimarchi Thomas